Liesbeth Hof holds a Master in Medical Biology and brings over 20 years of international experience in the pharmaceutical and biotech industries. Her career began at the Ministry of Health, after which she gained invaluable experience at Novartis in Switzerland, and later United Kingdom, specializing in  global regulatory affairs. Transitioning from big pharma, she joined the consultancy firm ProPharma Group, where she led a team of consultants, was engaged in business development and supported start-ups and biotech companies with their development programs. Since 2022, Liesbeth has been working with AM-Pharma, where she oversees project management for development programs and ensures operational implementation. Throughout her career, Liesbeth drove diverse cross-functional global team, achieving successful regulatory submissions across various therapeutic areas, including orphan drugs. She has also played a pivotal role in strategic planning and milestone achievement at key stages of the product’s life cycle.